\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ significant\\ for\\ r\\ eye\\ ptosis\\ and\\ general\\ significant\\ discomfort\\ due\\ to\\ pain\\.\ \(0\)\
\-\ scatter\\ laser\\ treatment\ \(0\)\
\-\ persistent\\ high\\ density\\ in\\ the\\ retro\\ orbital\\ region\\ on\\ the\\ right\\,\\ consistent\\ with\\ a\\ retinal\\ hemorrhage\\.\ \(0\)\
\-\ thickened\\ right\\ peri\\-orbital\\ soft\\ tissues\\ consistent\\ with\\ edema\\.\\ the\\ optic\\ nerve\\ is\\ intact\\.\\ \\ \ \(0\)\
\-\ the\\ left\\ globe\\ is\\ within\\ normal\\ limits\\.\\ \\ the\\ visualized\\ sinuses\\ are\\ within\\ normal\\ limits\\.\\ \\ the\\ osseous\\ structures\\ are\\ intact\\.\ \(0\)\
\-\ retinal\\ hemmorhage\\ secondary\\ to\\ diabetic\\ retinopathy\ \(0\)\
\-\ acute\\ glaucoma\ \(0\)\
\-\ intracranial\\ mass\ \(7\)\
\-\ foreign\\ body\\ or\\ corneal\\ abrasion\ \(0\)\
\-\ viral\\ or\\ bacterial\\ conjunctivitis\ \(0\)\
\-\ keratitis\\ due\\ to\\ herpes\\ simplex\ \(0\)\
\-\ orbital\\ or\\ periorbital\\ cellulitis\ \(0\)\
\-\ ophthalmic\\ zoster\ \(0\)\
\-\ uveitis\ \(9\)\
\-\ temporal\\ arteritis\ \(1\)\
\-\ optic\\ neuritis\ \(15\)\
\-\ 69\\ y\\/o\\ caucasian\\ male\\ with\\ pmhx\\ significant\\ for\\ poorly\\ controlled\\ diabetes\\ mellitus\\,\\ htn\\,\\ and\\ thrombocytopenia\\ \\(most\\ likely\\ secondary\\ to\\ myelofibrosis\\)\\ presented\\ to\\ er\\ with\\ acute\\ onset\\ of\\ unilateral\\ \\(r\\)\\ retroorbital\\ pain\\ without\\ radiation\\.\\ \\ pain\\ is\\ described\\ as\\ sharp\\ and\\ pressure\\ over\\ the\\ right\\ eye\\ with\\ involvement\\ of\\ the\\ frontotemporal\\ region\\ of\\ the\\ head\\.\\ \\ pt\\ denies\\ hx\\ of\\ trauma\\,\\ change\\ in\\ mental\\ status\\,\\ new\\ rashes\\ on\\ the\\ face\\,\\ or\\ recent\\ travel\\.\ \(0\)\
\-\ diabetic\\ retinopathy\\ is\\ a\\ complication\\ of\\ diabetes\\ and\\ a\\ leading\\ cause\\ of\\ blindness\\.\\ it\\ occurs\\ when\\ diabetes\\ damages\\ the\\ tiny\\ blood\\ vessels\\ inside\\ the\\ retina\\,\\ the\\ light\\-sensitive\\ tissue\\ at\\ the\\ back\\ of\\ the\\ eye\\.\\ at\\ first\\,\\ patients\\ with\\ diabetic\\ retinopathy\\ may\\ be\\ asymptomatic\\ with\\ no\\ changes\\ in\\ vision\\.\\ but\\ over\\ time\\,\\ diabetic\\ retinopathy\\ can\\ get\\ worse\\ and\\ cause\\ vision\\ loss\\.\\ diabetic\\ retinopathy\\ usually\\ affects\\ both\\ eyes\\.\ \(0\)\
\-\ diabetic\\ retinopathy\\ has\\ four\\ stages\\:\ \(0\)\
\-\ \\â\\€\\¢\\ mild\\ nonproliferative\\ retinopathy\ \(0\)\
\-\ at\\ this\\ earliest\\ stage\\,\\ microaneurysms\\ occur\\.\\ they\\ are\\ small\\ areas\\ of\\ balloon\\-like\\ swelling\\ in\\ the\\ retina\\'s\\ tiny\\ blood\\ vessels\\.\ \(0\)\
\-\ \\â\\€\\¢\\ moderate\\ nonproliferative\\ retinopathy\\ \ \(0\)\
\-\ as\\ the\\ disease\\ progresses\\,\\ some\\ blood\\ vessels\\ that\\ nourish\\ the\\ retina\\ are\\ blocked\\.\ \(0\)\
\-\ \\â\\€\\¢\\ severe\\ nonproliferative\\ retinopathy\\ \ \(0\)\
\-\ many\\ more\\ blood\\ vessels\\ are\\ blocked\\,\\ depriving\\ several\\ areas\\ of\\ the\\ retina\\ with\\ their\\ blood\\ supply\\.\\ these\\ areas\\ of\\ the\\ retina\\ send\\ signals\\ to\\ the\\ body\\ to\\ grow\\ new\\ blood\\ vessels\\ for\\ nourishment\\.\ \(0\)\
\-\ \\â\\€\\¢\\ proliferative\\ retinopathy\\ \ \(0\)\
\-\ at\\ this\\ advanced\\ stage\\,\\ the\\ signals\\ sent\\ by\\ the\\ retina\\ for\\ nourishment\\ trigger\\ the\\ growth\\ of\\ new\\ blood\\ vessels\\.\\ this\\ condition\\ is\\ called\\ proliferative\\ retinopathy\\.\\ these\\ new\\ blood\\ vessels\\ are\\ abnormal\\ and\\ fragile\\.\\ they\\ grow\\ along\\ the\\ retina\\ and\\ along\\ the\\ surface\\ of\\ the\\ clear\\,\\ vitreous\\ gel\\ that\\ fills\\ the\\ inside\\ of\\ the\\ eye\\.\\ \ \(0\)\
\-\ blood\\ vessels\\ damaged\\ from\\ diabetic\\ retinopathy\\ can\\ cause\\ vision\\ loss\\ in\\ two\\ ways\\:\ \(0\)\
\-\ fragile\\,\\ abnormal\\ blood\\ vessels\\ can\\ develop\\ and\\ leak\\ blood\\ into\\ the\\ center\\ of\\ the\\ eye\\,\\ blurring\\ vision\\.\\ \ \(0\)\
\-\ fluid\\ can\\ leak\\ into\\ the\\ center\\ of\\ the\\ macula\\,\\ the\\ part\\ of\\ the\\ eye\\ where\\ sharp\\,\\ straight\\-ahead\\ vision\\ occurs\\.\\ the\\ fluid\\ makes\\ the\\ macula\\ swell\\ resulting\\ in\\ macular\\ edema\\.\\ it\\ can\\ occur\\ at\\ any\\ stage\\ of\\ diabetic\\ retinopathy\\,\\ although\\ it\\ is\\ more\\ likely\\ to\\ occur\\ as\\ the\\ disease\\ progresses\\.\\ about\\ half\\ of\\ the\\ people\\ with\\ proliferative\\ retinopathy\\ also\\ have\\ macular\\ edema\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ retinopathy\\:\\ 0\\.18910120262757346\ \(0\)\
\-\ retina\\:\\ 0\\.08221591838471157\ \(0\)\
\-\ diabetic\\:\\ 0\\.07849148241941832\ \(0\)\
\-\ vessels\\:\\ 0\\.059542615666425\ \(0\)\
\-\ nonproliferative\\:\\ 0\\.05085876013826826\ \(0\)\
\-\ blood\\:\\ 0\\.04933946499538903\ \(0\)\
\-\ eye\\:\\ 0\\.04135857469744513\ \(0\)\
\-\ vision\\:\\ 0\\.03796138436068188\ \(0\)\
\-\ proliferative\\:\\ 0\\.03702474894904689\ \(0\)\
\-\ nourishment\\:\\ 0\\.03390584009217884\ \(0\)\
\-\ fragile\\:\\ 0\\.03390584009217884\ \(0\)\
\-\ macula\\:\\ 0\\.02968040821268611\ \(0\)\
\-\ signals\\:\\ 0\\.026421570288119943\ \(0\)\
\-\ macular\\:\\ 0\\.026421570288119943\ \(0\)\
\-\ blocked\\:\\ 0\\.025907988008794857\ \(0\)\
\-\ diabetes\\:\\ 0\\.024407024684399575\ \(0\)\
\-\ new\\:\\ 0\\.022906061360004296\ \(0\)\
\-\ inside\\:\\ 0\\.02238379288620195\ \(0\)\
\-\ retinal\\:\\ 0\\.022017215271569933\ \(0\)\
\-\ progresses\\:\\ 0\\.022017215271569933\ \(0\)\
\-\ grow\\:\\ 0\\.021374699561326985\ \(0\)\
\-\ stage\\:\\ 0\\.021029044782278922\ \(0\)\
\-\ tiny\\:\\ 0\\.0205760866198722\ \(0\)\
\-\ leak\\:\\ 0\\.019717842191740623\ \(0\)\
\-\ can\\:\\ 0\\.01863675338912567\ \(0\)\
\-\ occur\\:\\ 0\\.01849642285835503\ \(0\)\
\-\ sharp\\:\\ 0\\.017791783392077203\ \(0\)\
\-\ scatter\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ light\\-sensitive\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ microaneurysms\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ balloon\\-like\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ nourish\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ depriving\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ straight\\-ahead\\:\\ 0\\.01695292004608942\ \(0\)\
\-\ cause\\:\\ 0\\.016680361307030576\ \(0\)\
\-\ areas\\:\\ 0\\.016588541372573463\ \(0\)\
\-\ center\\:\\ 0\\.016117483118008567\ \(0\)\
\-\ retroorbital\\:\\ 0\\.015619944698858756\ \(0\)\
\-\ orbital\\:\\ 0\\.015589786496802855\ \(0\)\
\-\ optic\\:\\ 0\\.015214253921557024\ \(0\)\
\-\ r\\:\\ 0\\.014927094195522333\ \(0\)\
\-\ peri\\-orbital\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ keratitis\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ damages\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ swell\\:\\ 0\\.014840204106343055\ \(0\)\
\-\ edema\\:\\ 0\\.013943789362103602\ \(0\)\
\-\ retro\\:\\ 0\\.013857847137562305\ \(0\)\
\-\ myelofibrosis\\:\\ 0\\.013857847137562305\ \(0\)\
\-\ send\\:\\ 0\\.013857847137562305\ \(0\)\
\-\ trigger\\:\\ 0\\.013857847137562305\ \(0\)\
\-\ gel\\:\\ 0\\.013857847137562305\ \(0\)\
\-\ limits\\:\\ 0\\.013546975381700023\ \(0\)\
\-\ uveitis\\:\\ 0\\.01350722875911239\ \(0\)\
\-\ occurs\\:\\ 0\\.013489425871404975\ \(0\)\
\-\ are\\:\\ 0\\.01344085237534156\ \(0\)\
\-\ significant\\:\\ 0\\.01325681048685129\ \(0\)\
\-\ abrasion\\:\\ 0\\.013210785144059971\ \(0\)\
\-\ conjunctivitis\\:\\ 0\\.013210785144059971\ \(0\)\
\-\ hemmorhage\\:\\ 0\\.012953994004397429\ \(0\)\
\-\ zoster\\:\\ 0\\.012953994004397429\ \(0\)\
\-\ vitreous\\:\\ 0\\.012953994004397429\ \(0\)\
\-\ frontotemporal\\:\\ 0\\.01272748816659669\ \(0\)\
\-\ ways\\:\\ 0\\.01272748816659669\ \(0\)\
\-\ thrombocytopenia\\:\\ 0\\.01252487179033164\ \(0\)\
\-\ earliest\\:\\ 0\\.01252487179033164\ \(0\)\
\-\ glaucoma\\:\\ 0\\.012341582983015631\ \(0\)\
\-\ corneal\\:\\ 0\\.012341582983015631\ \(0\)\
\-\ blurring\\:\\ 0\\.012341582983015631\ \(0\)\
\-\ simplex\\:\\ 0\\.012174253411881726\ \(0\)\
\-\ intact\\:\\ 0\\.012072171621916218\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.012053956550737599\ \(0\)\
\-\ damaged\\:\\ 0\\.011877809796829307\ \(0\)\
\-\ they\\:\\ 0\\.01184210048648964\ \(0\)\
\-\ blindness\\:\\ 0\\.011745131197815938\ \(0\)\
\-\ laser\\:\\ 0\\.011621018657166764\ \(0\)\
\-\ ptosis\\:\\ 0\\.011394512819366027\ \(0\)\
\-\ rashes\\:\\ 0\\.011290537393846266\ \(0\)\
\-\ travel\\:\\ 0\\.011290537393846266\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.011191896443100976\ \(0\)\
\-\ at\\:\\ 0\\.011132338007996472\ \(0\)\
\-\ it\\:\\ 0\\.011081817603075096\ \(0\)\
\-\ periorbital\\:\\ 0\\.010923123476994902\ \(0\)\
\-\ arteritis\\:\\ 0\\.010923123476994902\ \(0\)\
\-\ people\\:\\ 0\\.010923123476994902\ \(0\)\
\-\ along\\:\\ 0\\.010861745680225063\ \(0\)\
\-\ body\\:\\ 0\\.010674091202650325\ \(0\)\
\-\ herpes\\:\\ 0\\.010614772226850326\ \(0\)\
\-\ fills\\:\\ 0\\.010477351142269277\ \(0\)\
\-\ neuritis\\:\\ 0\\.010412155850585275\ \(0\)\
\-\ the\\:\\ 0\\.010368696352771935\ \(0\)\
\-\ 69\\:\\ 0\\.0103490984990026\ \(0\)\
\-\ mellitus\\:\\ 0\\.0103490984990026\ \(0\)\
\-\ get\\:\\ 0\\.010061537472135363\ \(0\)\
\-\ \\,\\:\\ 0\\.00989132931697781\ \(0\)\
\-\ controlled\\:\\ 0\\.009858921095870311\ \(0\)\
\-\ stages\\:\\ 0\\.009858921095870311\ \(0\)\
\-\ cellulitis\\:\\ 0\\.009765093857082942\ \(0\)\
\-\ pmhx\\:\\ 0\\.009719842900524876\ \(0\)\
\-\ globe\\:\\ 0\\.009548790042800846\ \(0\)\
\-\ loss\\:\\ 0\\.009540246817186307\ \(0\)\
\-\ abnormal\\:\\ 0\\.00937343169351889\ \(0\)\
\-\ affects\\:\\ 0\\.009354374433432828\ \(0\)\
\-\ fluid\\:\\ 0\\.009340919633091744\ \(0\)\
\-\ region\\:\\ 0\\.009283081643228126\ \(0\)\
\-\ likely\\:\\ 0\\.009270346022829449\ \(0\)\
\-\ secondary\\:\\ 0\\.009188576794264644\ \(0\)\
\-\ supply\\:\\ 0\\.009144375795038615\ \(0\)\
\-\ makes\\:\\ 0\\.009111501884732268\ \(0\)\
\-\ htn\\:\\ 0\\.009047393384217667\ \(0\)\
\-\ eyes\\:\\ 0\\.008838482151519984\ \(0\)\
\-\ due\\:\\ 0\\.008770296742126307\ \(0\)\
\-\ half\\:\\ 0\\.008675871789927554\ \(0\)\
\-\ called\\:\\ 0\\.008624586699384937\ \(0\)\
\-\ these\\:\\ 0\\.008553248815222462\ \(0\)\
\-\ sinuses\\:\\ 0\\.008455149646480578\ \(0\)\
\-\ bacterial\\:\\ 0\\.008409359937454196\ \(0\)\
\-\ advanced\\:\\ 0\\.008409359937454196\ \(0\)\
\-\ over\\:\\ 0\\.008367856115922933\ \(0\)\
\-\ sent\\:\\ 0\\.008364635202522914\ \(0\)\
\-\ viral\\:\\ 0\\.008278190225864708\ \(0\)\
\-\ discomfort\\:\\ 0\\.008236382559256235\ \(0\)\
\-\ more\\:\\ 0\\.00821990888196987\ \(0\)\
\-\ develop\\:\\ 0\\.008195464485319149\ \(0\)\
\-\ unilateral\\:\\ 0\\.008155398933582915\ \(0\)\
\-\ hx\\:\\ 0\\.008135674894799858\ \(0\)\
\-\ acute\\:\\ 0\\.008114920496563444\ \(0\)\
\-\ foreign\\:\\ 0\\.008096823534573859\ \(0\)\
\-\ consistent\\:\\ 0\\.008058839495504629\ \(0\)\
\-\ face\\:\\ 0\\.008058741559004283\ \(0\)\
\-\ complication\\:\\ 0\\.008058741559004283\ \(0\)\
\-\ poorly\\:\\ 0\\.008021399086202165\ \(0\)\
\-\ part\\:\\ 0\\.007966710749047291\ \(0\)\
\-\ leading\\:\\ 0\\.007861789625488764\ \(0\)\
\-\ caucasian\\:\\ 0\\.007844846106869236\ \(0\)\
\-\ into\\:\\ 0\\.007820486030614257\ \(0\)\
\-\ or\\:\\ 0\\.007704021145874674\ \(0\)\
\-\ mental\\:\\ 0\\.007667701320508072\ \(0\)\
\-\ as\\:\\ 0\\.007457177918619968\ \(0\)\
\-\ pe\\:\\ 0\\.007382278233742161\ \(0\)\
\-\ thickened\\:\\ 0\\.007369061158188773\ \(0\)\
\-\ worse\\:\\ 0\\.007279000966488583\ \(0\)\
\-\ surface\\:\\ 0\\.007254025590475484\ \(0\)\
\-\ resulting\\:\\ 0\\.007217160367191407\ \(0\)\
\-\ their\\:\\ 0\\.007192970401408983\ \(0\)\
\-\ growth\\:\\ 0\\.007145484607965961\ \(0\)\
\-\ four\\:\\ 0\\.0071337941347421495\ \(0\)\
\-\ described\\:\\ 0\\.0069987859449859025\ \(0\)\
\-\ osseous\\:\\ 0\\.006977178111780276\ \(0\)\
\-\ intracranial\\:\\ 0\\.006945214878634044\ \(0\)\
\-\ denies\\:\\ 0\\.006934677444471303\ \(0\)\
\-\ general\\:\\ 0\\.006924197435302909\ \(0\)\
\-\ condition\\:\\ 0\\.006872637324820877\ \(0\)\
\-\ many\\:\\ 0\\.006754256761360429\ \(0\)\
\-\ tissues\\:\\ 0\\.006744712935702488\ \(0\)\
\-\ where\\:\\ 0\\.006707004336878687\ \(0\)\
\-\ visualized\\:\\ 0\\.006651792594797088\ \(0\)\
\-\ temporal\\:\\ 0\\.0065805593800271865\ \(0\)\
\-\ to\\:\\ 0\\.006570278591430558\ \(0\)\
\-\ persistent\\:\\ 0\\.0065545127932815\ \(0\)\
\-\ is\\:\\ 0\\.006487970519823758\ \(0\)\
\-\ moderate\\:\\ 0\\.006461917901170763\ \(0\)\
\-\ pressure\\:\\ 0\\.00645371713427373\ \(0\)\
\-\ change\\:\\ 0\\.006405233635530467\ \(0\)\
\-\ about\\:\\ 0\\.006334725973277408\ \(0\)\
\-\ structures\\:\\ 0\\.006327049009297528\ \(0\)\
\-\ er\\:\\ 0\\.0063042003018230035\ \(0\)\
\-\ within\\:\\ 0\\.0062697361861003146\ \(0\)\
\-\ pt\\:\\ 0\\.006109930297370678\ \(0\)\
\-\ clear\\:\\ 0\\.006076012717589703\ \(0\)\
\-\ involvement\\:\\ 0\\.006022958955053494\ \(0\)\
\-\ pain\\:\\ 0\\.006020816351138854\ \(0\)\
\-\ nerve\\:\\ 0\\.00592105024324482\ \(0\)\
\-\ status\\:\\ 0\\.005866014079195488\ \(0\)\
\-\ that\\:\\ 0\\.005676848955995475\ \(0\)\
\-\ for\\:\\ 0\\.0056085242203285784\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.005554985380761706\ \(0\)\
\-\ although\\:\\ 0\\.005549864001108853\ \(0\)\
\-\ this\\:\\ 0\\.005545022384504614\ \(0\)\
\-\ recent\\:\\ 0\\.005524459709307303\ \(0\)\
\-\ first\\:\\ 0\\.005514391220742024\ \(0\)\
\-\ swelling\\:\\ 0\\.005474636276886794\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.00546972420033853\ \(0\)\
\-\ back\\:\\ 0\\.005421281414129764\ \(0\)\
\-\ density\\:\\ 0\\.005406983378576845\ \(0\)\
\-\ radiation\\:\\ 0\\.005392790864542955\ \(0\)\
\-\ disease\\:\\ 0\\.005372067466214247\ \(0\)\
\-\ several\\:\\ 0\\.0052828708379276685\ \(0\)\
\-\ right\\:\\ 0\\.005201721398713942\ \(0\)\
\-\ onset\\:\\ 0\\.005187348511394519\ \(0\)\
\-\ any\\:\\ 0\\.005174682755908258\ \(0\)\
\-\ normal\\:\\ 0\\.005152355594611927\ \(0\)\
\-\ severe\\:\\ 0\\.005056365000126932\ \(0\)\
\-\ usually\\:\\ 0\\.00499024664205146\ \(0\)\
\-\ some\\:\\ 0\\.00499024664205146\ \(0\)\
\-\ in\\:\\ 0\\.004862275732387557\ \(0\)\
\-\ changes\\:\\ 0\\.004709707646605886\ \(0\)\
\-\ when\\:\\ 0\\.004706406226184626\ \(0\)\
\-\ two\\:\\ 0\\.004706406226184626\ \(0\)\
\-\ head\\:\\ 0\\.0046607717511036465\ \(0\)\
\-\ time\\:\\ 0\\.004641540821614063\ \(0\)\
\-\ y\\/o\\:\\ 0\\.004551209672730079\ \(0\)\
\-\ high\\:\\ 0\\.004497203963609261\ \(0\)\
\-\ trauma\\:\\ 0\\.004494247657226787\ \(0\)\
\-\ presented\\:\\ 0\\.004479533913504633\ \(0\)\
\-\ \\:\\:\\ 0\\.004347210830733327\ \(0\)\
\-\ mild\\:\\ 0\\.00432741048832911\ \(0\)\
\-\ patients\\:\\ 0\\.004253028075703896\ \(0\)\
\-\ both\\:\\ 0\\.004196538443627156\ \(0\)\
\-\ of\\:\\ 0\\.004032823873776523\ \(0\)\
\-\ soft\\:\\ 0\\.004001782238449135\ \(0\)\
\-\ tissue\\:\\ 0\\.0038950407470242187\ \(0\)\
\-\ without\\:\\ 0\\.0038692560891503084\ \(0\)\
\-\ most\\:\\ 0\\.0037939137340924542\ \(0\)\
\-\ small\\:\\ 0\\.0037857217007329206\ \(0\)\
\-\ \\'s\\:\\ 0\\.0036231665737827792\ \(0\)\
\-\ may\\:\\ 0\\.003604477632496392\ \(0\)\
\-\ have\\:\\ 0\\.0035585347660867152\ \(0\)\
\-\ but\\:\\ 0\\.003504814040449111\ \(0\)\
\-\ treatment\\:\\ 0\\.0033261864607709367\ \(0\)\
\-\ also\\:\\ 0\\.0032396530647502914\ \(0\)\
\-\ has\\:\\ 0\\.0030859614817197656\ \(0\)\
\-\ male\\:\\ 0\\.002971549111322064\ \(0\)\
\-\ on\\:\\ 0\\.0027841962014054926\ \(0\)\
\-\ \\(\\:\\ 0\\.002778314331707156\ \(0\)\
\-\ and\\:\\ 0\\.0027693693189572073\ \(0\)\
\-\ \\)\\:\\ 0\\.0027443757388973273\ \(0\)\
\-\ by\\:\\ 0\\.0027362901985478363\ \(0\)\
\-\ be\\:\\ 0\\.0025341475448921714\ \(0\)\
\-\ from\\:\\ 0\\.0024354532945273315\ \(0\)\
\-\ a\\:\\ 0\\.0022880757797226997\ \(0\)\
\-\ mass\\:\\ 0\\.002285501936437624\ \(0\)\
\-\ with\\:\\ 0\\.002025072278478861\ \(0\)\
\-\ \\.\\:\\ 0\\.0019797818208135425\ \(0\)\
\-\ left\\:\\ 0\\.00183866397937099\ \(0\)\
\-\ no\\:\\ 0\\.0016547002898150039\ \(0\)\
